Pharmacogenetics Flashcards
What are some types of non-genetic factors?
disease state
age
diet
stress
previous drug exposure
Pharmacogenetics
study of how genetic variation affects drug response
What percentage of variability in pharmacokinetic half-life is associated with genetic makeup?
75-85%
What does pharmacogenetics help with?
approaches to drug dosing that considers a patient’s genetic makeup to maximize a positive therapeutic outcome to drug therapy while minimizing adverse effects
Advantages of pharmacogentics
genetic testing of patients means optimal doses of drugs to optimize therapeutic outcomes
personalized medicine helps with better treatment outcomes, greater drug efficacy, minimize drug toxicity and ADRs
Polymorphism
mutation in a gene DNA sequence that occurs at a frequency of greater than 1% in a population
Polymorphism in genes causes drug response to?
vary
SNP
single nucleotide polymorphism
nucleotide substitution that results in a replacement of an amino acid codon, leading to a single amino acid substitution in a protein
If an SNP occurs in a receptor there could be a change in ligand?
binding affinity/efficacy
If a SNP is in an enzyme it can result in a change in?
Metabolic activity
Indel polymorphism
insertion/deletion of bases in a gene that can result in changes in peptide length
A gene allele with a polymorphism can be ?
dominant, recessive, or co-dominant
Phenotypic expression of the genetic trait can vary depending on whether the patient inherited x or y genes?
homozygous or heterozygous
Genetic polymorphisms can occur across ethnic groups or be?
race or ethnic specific
Is atenolol more effective in Caucasian or African American patients?
Caucasians due to genetic polymorphisms in African Americans
Variations in drug pharmacokinetics are based on?
genetic polymorphisms in metabolic enzyms
What percentages of Rx drugs are metabolized by Cytochrome P450 enzymes?
70-90%
Impacts of genetic polymorphisms of metabolic enzymes
decrease metabolism of drugs
decreased metabolism of prodrugs
change plasma protein binding
alter efficiency of transporter enzymes
Genetic polymorphism decrease metabolic enzymes of drugs by
increasing [blood]
prolonged duration of action
prolonged half-life
Genetic polymorphisms decrease metabolism of prodrugs by?
decreasing [active metabolite]
decreased therapeutic response
Patient genotypes related to polymorphisms can result in
Ultra-rapid metabolizer- substantially incr metabolic activity
extensive metabolizer- normal
intermediate metabolizer- reduced metabolic activity
poor metabolizer- little/no functional metabolic activity
Impact of genetic polymorphisms on pharmacodynamics
alter binding affinity of drugs for receptors
alter ability of drug to fully activate receptors
alter therapeutic response of drug
alter drug safety
Warfarin varies with polymorphism x. What happens as a result?
VKORC1
reduces vitamin K dependent clotting factors
results in increased [warfarin] and hemorrhage
Codeine is a prodrug metabolized by
CYP2D6
If a patient has a duplication of a gene, they would become an ultra rapid metabolizer of codeine resulting in
symptoms of opiate overdose
CYP2C9
enzyme responsible for 10% of drug metabolism
CYP2D6
enzyme responsible for 20-30% of drug metabolism
CYP3A4
enzyme responsible for 40-45% of drug metabolism